CDK4 and cervical cancer: Moreover, McLaughlin-Drubin et al[51] have recently evidenced that p16INK4A, a tumor suppressor highly expressed in response to E7, displays an oncogenic activity in HPV16+ cervical cancer cells depending on inhibition of CDK4/CDK6 and cellular context.